EP3544411A1 - Zellkulturen der allackerbeere (arcticus rubus), verfahren zur herstellung von allackerbeerenzellkulturen, zusammensetzungen mit allackerbeerenzellkulturen und verwendung von allackerbeerenzellkulturen - Google Patents

Zellkulturen der allackerbeere (arcticus rubus), verfahren zur herstellung von allackerbeerenzellkulturen, zusammensetzungen mit allackerbeerenzellkulturen und verwendung von allackerbeerenzellkulturen

Info

Publication number
EP3544411A1
EP3544411A1 EP17873936.3A EP17873936A EP3544411A1 EP 3544411 A1 EP3544411 A1 EP 3544411A1 EP 17873936 A EP17873936 A EP 17873936A EP 3544411 A1 EP3544411 A1 EP 3544411A1
Authority
EP
European Patent Office
Prior art keywords
irradiation
arctic bramble
bramble
arctic
cell culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17873936.3A
Other languages
English (en)
French (fr)
Other versions
EP3544411A4 (de
Inventor
Liisa Nohynek
Riitta PUUPPONEN-PIMIÄ
Kirsi-Marja Oksman-Caldentey
Heiko Rischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valtion Teknillinen Tutkimuskeskus
Original Assignee
Valtion Teknillinen Tutkimuskeskus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valtion Teknillinen Tutkimuskeskus filed Critical Valtion Teknillinen Tutkimuskeskus
Publication of EP3544411A1 publication Critical patent/EP3544411A1/de
Publication of EP3544411A4 publication Critical patent/EP3544411A4/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H3/00Processes for modifying phenotypes, e.g. symbiosis with bacteria
    • A01H3/02Processes for modifying phenotypes, e.g. symbiosis with bacteria by controlling duration, wavelength, intensity, or periodicity of illumination
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • A01H4/002Culture media for tissue culture
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • A01H4/005Methods for micropropagation; Vegetative plant propagation using cell or tissue culture techniques
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A01N43/42Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/04Plant cells or tissues
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair

Definitions

  • ARCTIC BRAMBLE (RUBUS ARCTICUS) CELL CULTURES, METHOD FOR PRODUCING ARCTIC BRAMBLE CELL CULTURES, COMPOSITIONS COMPRISING ARCTIC BRAMBLE CELL CULTURES AND USE OF ARCTIC BRAMBLE CELL CULTURES
  • the present invention relates to a method for producing artic bramble cell cultures.
  • the invention relates further to arctic bramble cell cultures obtained by the method.
  • the invention relates also to compositions comprising arctic bramble cell cultures, and to the use of the arctic bramble cell cultures in cosmetic, hygiene and personal care applications, in food, nutrition, nutraceuticals, pharmaceutical products, and for providing aroma, flavor and/or color to the products.
  • Arctic bramble (Rubus arcticus) is a unique arctic berry with special chemical and flavor components, which are exploited by food and beverage industry.
  • Arctic bramble is a rare aromatic berry species. It is rich in phenolic compounds, such as tannins and anthocyanins with known beneficial effects to the human health.
  • phenolic compounds such as tannins and anthocyanins
  • the availability and quality of wild berry material is strongly affected by seasonal variations and by chemical and biological pollutants.
  • the annual crop of both wild and cultivated berries is extremely low, particularly because these berries are very sensitive to climate changes and plant pathogenic microbes, and they are difficult to cultivate. Therefore, the availability of berry material for industry is insufficient.
  • Callus is similar as plant stem cell in its ability to differentiate, but the two are different in their origin. While plant stem cell exists in the meristematic tissues of plant, callus is obtained as a temporary response to cure wound in somatic cell. Only plant stem cells embedded in meristems can divide and give rise to cells that differentiate while giving rise to new stem cells. Cultured callus-derived cells provide a cost-effective and sustainable source of important natural products.
  • WO 2013/124540 Al discloses cosmetic compositions containing cloudberry cell culture preparation, where said compositions have antioxidant and anti-aging effect. It protects the skin from UV radiation effects and it has effect on the procollagen I synthesis of aged fibroblasts.
  • callus is first produced from sterile cuts of cloudberry plant. The material is maintained on a medium favoring continuous growth of the non- differentiated cells. Selected callus is then chosen for suspension culture, which is stepwise scaled up to large scale cultivation in a bioreactor. The biomass is harvested, followed by washing with water and freeze-drying. The freeze-dried powder may be used as such in cosmetic compositions or the powder may be extracted with methanol or ethanol and filtered prior to use.
  • Cell culture technology offers a sustainable approach for utilizing the biosynthetic capacity of arctic bramble plant to produce valuable phenolic metabolites. Even new compounds, which cannot be found in the natural plant and berries, can be produced utilizing modified biosynthetic pathways.
  • An object of the invention is to provide a method for producing arctic bramble cell cultures. Another object of the invention is to provide a method for producing arctic bramble cell cultures, said method being suitable particularly for larger industrial scale. Another object of the invention is to provide compositions comprising said arctic bramble cell cultures.
  • An object of the invention is to provide arctic bramble cell cultures. Another object of the invention is to use of the obtained arctic bramble cell cultures in cosmetic, hygiene and personal care products, as well as for food, nutrition, nutraceuticals, pharmaceuticals and as food flavors and colorants.
  • the present invention generally concerns producing arctic bramble cell cultures having unique compositions, where cell cultures are illuminated with LED-lights favoring strong production of anthocyanins in the culture.
  • the method of the invention for producing arctic bramble cell culture comprises two stages, where in the first stage arctic bramble callus line is cultured in a liquid medium comprising a medium used for plant cell and tissue culture, under day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, to obtain primary arctic bramble suspension cell culture, and in the second stage the primary arctic bramble suspension cell culture is up-scaled in at least two steps in the liquid medium; and irradiation with LED lights is used in the first stage or in the second stage or in both stages.
  • the invention also relates to compositions comprising arctic bramble cell cultures obtained by the method, said arctic bramble cell cultures comprising one or more of anthocyanins, procyanidins, phenolic acids, vitamins and fatty acids, beneficial for human health.
  • the invention further relates to the use of said arctic bramble cell cultures in cosmetic compositions, hygiene and personal care products, as well as in foods, feeds, pet foods nutritional compositions, nutraceutical compositions, pharmaceutical compositions, for example for providing effects beneficial to the health, and as providing flavor, aroma and/or color to the products.
  • cell culture refers here to callus or cell suspension culture or hairy root originating from arctic bramble (Rubus arcticus) plant, where said plant includes berries, seeds, flowers, roots, leaves and pieces of plant stem, one or more of hypocotyl, cotyledon, leaf section, stem section, root section of a seedling; stem section including a node or an internode, and a leaf section of a mature plant.
  • arctic bramble Rubus arcticus
  • MS medium refers here to Murashige and Skoog medium having a pH of 5.8, widely used in the field of plant cell and tissue culture.
  • the MS medium may be modified, where the MS medium is supplemented with additions of sucrose, plant growth regulators, also called plant growth hormones, the pH may be adjusted, and for obtaining solid medium agar or gelrite may be added.
  • LED light carried out as intermitting irradiation refers here to illumination/irradiation carried out in intermittent periods with LED light irradiation (light period) and without LED light irradiation (dark period), where the dark period may be from 1 to 23 hours and the light period may be from 1 to 23 hours.
  • An example of intermitting irradiation comprises irradiation carried as day-night irradiation (16/8hours).
  • Normal light refers here to incandescent light having illumination/irradiation intensity of 50-300 Ix.
  • Figure 1 shows anthocyanin contents of arctic bramble cell cultures obtained with the method of the invention using the specified irradiation with LED lights and without it.
  • Arctic bramble cell culture may be established from wild or cultured arctic bramble plant materials. Examples of such materials are wild arctic bramble plants. Said plants may be collected for example from the northern region in Finland.
  • Callus may be produced from sterile pieces of in vitro grown arctic bramble plants, generated from sterilized pieces of the plant, or alternatively from surface sterilized pieces of arctic bramble plant materials.
  • sterile pieces of in vitro grown arctic bramble plants generated from sterilized pieces of the plant are used in the method.
  • the callus is grown in vitro at sterile conditions, and it is maintained on a medium favoring continuous growth of the non-differentiated cells. Different callus lines (cell cultures) may be separated based on callus color. Particularly suitably bright colored callus of uniform quality is selected by sub-culturing. Typically, at least six different intensely colored callus lines may be selected, stabilized and maintained.
  • At least one selected callus line is suitably chosen for suspension culture.
  • at least one selected arctic bramble callus line (such as intensely colored callus line) is suspension cultured.
  • the suspension culture is up-scaled to produce the arctic bramble cell cultures in amounts suitable for large industrial scale.
  • the obtained cell culture is suitably cryo-preserved to provide a stable powdery product.
  • arctic bramble cell cultures having several advantageous effects could be obtained effectively and consistently on a large industrial scale.
  • the obtained arctic bramble cell cultures exhibit valuable bioactivities and other properties.
  • the method is sustainable and continuously large amounts of the arctic bramble cell culture may be produced.
  • the phenolic profiles of the obtained arctic bramble cell cultures are unique and different compared to the arctic bramble berry fruit.
  • High amounts of natural colorants, i.e. anthocyanins and other valuable phenolic compounds may be produced with the method, in significant amounts.
  • the cell cultures also contain natural aromas, flavors and lipids with beneficial fatty acid composition, which are desired ingredients for example in cosmetic, nutraceutical, nutritional and hygiene preparations.
  • the cell cultures can be generated around the year, on an industrial scale, with consistent quality and composition, which can be constantly monitored.
  • the arctic bramble (Rubus arcticus) plant material refers here to berries, seeds, flowers, roots, leaves and pieces of plant stem of arctic bramble plant, including one or more of hypocotyl, cotyledon, leaf section, stem section, root section of a seedling; stem section including a node or an internode, and a leaf section of a mature plant. Said plant material may originate from wild plants or cultivated plants. Formation of calli
  • Callus may be produced from sterile pieces of in vitro grown arctic bramble plants, generated from sterilized pieces of arctic bramble plant material, or alternatively from surface sterilized pieces of arctic bramble plant material.
  • callus produced from sterile pieces of in vitro grown arctic bramble plants, generated from sterilized pieces of arctic bramble plant material is used.
  • Calli formed on arctic bramble explants (cell callus of arctic bramble cells derived from arctic bramble plant) is obtained.
  • the plant material is suitably cut into pieces.
  • the pieces may have size of about 0.5 - 10 cm.
  • the pieces of the plant material are treated with at least one surface sterilizing solution, preferably with an ethanol solution followed by hypochlorite solution, to obtain surface sterilized pieces.
  • the ethanol solution comprises suitably at least 50 % v/v, preferably at least 65 % v/v of ethanol in water.
  • the hypochlorite solution comprises from 1 to 3 % by weight of hypochlorite in water.
  • the surface sterilized pieces are rinsed with sterile water and dried.
  • the surface sterilized (sterile) pieces may be used for the formation of the calli, however preferably sterile pieces of in vitro grown arctic bramble plants are used for the formation of the calli.
  • the surface sterilized pieces are transferred to a solid medium used for plant cell and tissue culture, without plant growth regulators, followed by incubating the pieces with the medium under sterile conditions, at the temperature of 20 - 28°C, under day-night illumination period under normal light (light-dark irradiation regime), for the time of 1 - 4 weeks, whereby roots and new leaves (in vitro grown arctic bramble plants) formed on the arctic bramble explants are obtained.
  • the day-night photoperiod under normal light refers to 16 : 8 photoperiod with irradiation 30-60 ⁇ / ⁇ 2 5.
  • the solid medium used for plant cell and tissue culture is MS medium, with added sucrose and agar.
  • the incubation is carried out in sealed sterile boxes.
  • the temperature is in the range of 20 - 25°C.
  • the incubation is carried out for 1 -3 weeks.
  • Sterile pieces of the in vitro grown arctic bramble plants, generated from sterilized pieces of the plant material, or pieces of surface sterilized plant material are incubated on a solid medium, suitably MS medium, without or alternatively with plant growth regulators (PGR) favoring development of undifferentiated plant material called callus.
  • a solid medium suitably MS medium
  • PGR plant growth regulators
  • the callus is grown in vitro at sterile conditions, and it is maintained on a medium favoring continuous growth of the non-differentiated cells, suitably MS medium.
  • a medium favoring continuous growth of the non-differentiated cells suitably MS medium.
  • Different callus lines (cell cultures) may be separated based on callus color.
  • the sterile pieces of the in vitro grown arctic bramble plants, or the surface sterilized pieces of arctic bramble plant are transferred to a solid medium used for plant cell and tissue culture, with plant growth regulators, followed by incubating the pieces with the medium, under sterile conditions, at the temperature of 20 - 28°C, under day- night (light-dark) irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, for the time of 1 - 8 weeks, at the pH in the range of 3 - 7, whereby callus formed on arctic bramble explants is obtained.
  • LED light is used, particularly preferably intermitting irradiation with LED light.
  • the day-night (light-dark) irradiation regime with normal light refers typically to a photoperiod 16 : 8 with irradiation 30-60 ⁇ / ⁇ 2 5.
  • the LED light or lights as defined on page 11 of this specification are preferably used.
  • the temperature is 20 - 25°C.
  • the incubation time is 1 - 4 weeks.
  • the pH is in the range of 4 - 6, particularly preferably 4 - 5.
  • the medium is a modified MS medium, where sucrose, agar or gelrite and plant growth regulators are added and where the pH is adjusted into the range of 3-7, preferably of 4 - 6.
  • said modified MS medium comprises 3 % w/v sucrose and 8 g L ⁇ l Bacto agar and plant growth regulators.
  • the plant growth regulators are selected from cytokines, auxins and combinations thereof.
  • cytokine is kinetin
  • a suitable auxin is a-naphthaleneacetic acid (NAA).
  • NAA a-naphthaleneacetic acid
  • 0.46 ⁇ kinetin and 5.37 ⁇ NAA is used.
  • the calli formed on the arctic bramble explants are separated from the explants and transferred to a fresh solid medium, preferable same as used in the forming of callus, and sub-cultured regularly favoring soft productive biomass. Cultured plant cells are totipotent, and when treated with PGRs the cells multiply continuously producing biomass consisting of identical cells.
  • Different callus lines are separated based on the color of the callus, for sub-culturing.
  • the sub-culturing is carried out suitably as follows.
  • the calli formed on the arctic bramble explants are separated from the explant and transferred to fresh solid medium and maintained under day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, preferably LED light is used, particularly preferably intermitting irradiation with LED light.
  • the medium is replaced with fresh medium with pH adjustment to 3-7, preferably to 4-6, particularly preferably to 4-5.
  • the separated callus is sub-cultured every 2-6 weeks, suitably by gentle division, for 2 to 8 months to obtain sub-cultured callus line.
  • the solid medium is a modified MS medium, where sucrose, agar or gelrite and plant growth regulator(s) are added and where the pH is adjusted into the range of 3-7, preferably of 4 - 6.
  • at least one PGR selected from cytokine, auxins and combinations thereof is included in said medium.
  • the temperature of 20 - 28°C, preferably 20-25°C is used. Sub-cultured callus lines are obtained.
  • the day-night (light-dark) irradiation regime with normal light refers typically to a photoperiod 16 : 8 with irradiation 30-60 ⁇ / ⁇ 2 5.
  • the LED light or lights as defined on page 11 of this specification are preferably used.
  • the method of the invention for producing arctic bramble cell cultures is particularly suitable for larger industrial scale, providing arctic bramble plant cell culture of consistent quality in high amounts.
  • Up-scaling of the primary arctic bramble suspension cell culture is realized by suspension culturing carried out in at least two steps.
  • the method of the invention for producing arctic bramble cell cultures comprises two stages, where the first stage comprises generation of primary arctic bramble suspension cell culture, where arctic bramble callus line is cultured in a liquid medium comprising a medium used for plant cell and tissue culture, under day-night irradiation under normal light, or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, to obtain primary arctic bramble suspension cell culture, and in the second stage the arctic bramble suspension cell culture is up-scaled in at least two steps, and irradiation with LED light is used in the first stage or in the second stage or in both stages.
  • the up-scaling comprises at least three steps. In another preferable embodiment, the upscaling comprises at least four steps.
  • LED light is used, particularly preferably intermitting irradiation with LED light.
  • LED light carried out as day-night irradiation is used.
  • Day- night irradiation refers typically to a photoperiod of 16: 8 respectively.
  • the first stage of the method comprises generation of primary arctic bramble suspension cell culture, where arctic bramble callus line is cultured in a liquid medium comprising a medium used for plant cell and tissue culture, to generate inoculum for larger scale.
  • At least one arctic bramble callus line is introduced in a liquid medium comprising a medium used for plant cell and tissue culture, and water, said liquid medium having a pH of 3-7, at the temperature of 20 - 28°C, under day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation preferably LED light is used, particularly preferably intermitting irradiation with LED light.
  • the suspension culture is initiated suitably with 0.1- 20 g of a selected arctic bramble callus line in 10-200 ml of the liquid medium.
  • the suspension culture is sub-cultured every 7-15 days intervals and stepwise up-scaled to 50-500 ml, preferably to 200-500 ml culture in a suitable vessel, such as an Erienmeyer flask.
  • a suitable vessel such as an Erienmeyer flask.
  • more than one replicate suspensions are cultured in the flasks, preferably at least two replicate suspensions.
  • the sub-culturing is carried out in the liquid medium as defined below. Any visually detectable clumps are removed, preferably after 2 - 4 sub- culturing, to provide a homogeneous suspension by visual inspection.
  • primary arctic bramble suspension cell culture is obtained as a finely divided and homogeneous suspension, when inspected visually.
  • the cells may be harvested using methods known in the art, and suspended in the fresh medium to obtain a homogeneous suspension.
  • the primary arctic bramble suspension cell culture (inoculum) is used in the second stage.
  • the water used in the method is selected from sterilized MQ-water, RO-water, and tap water, preferably high purity sterilized MQ-water or RO-water.
  • any medium used for plant cell and tissue culture may be used in the method, preferably the medium used for plant cell and tissue culture is a modified MS medium.
  • Said modified MS medium comprises sucrose, suitably 3 % w/v.
  • Said modified MS medium comprises plant growth regulators selected from cytokines, auxins and combinations thereof.
  • cytokine is kinetin
  • a suitable auxin is a-naphthaleneacetic acid (NAA).
  • NAA a-naphthaleneacetic acid
  • the pH of modified MS medium is adjusted into the range of 3-7, preferably of 4 - 6.
  • the day-night (light-dark) irradiation regime under normal light refers typically to a photoperiod 16 : 8 with irradiation 30-60 ⁇ / ⁇ 2 5.
  • the temperature is 22-25°C.
  • the first stage is suitably carried out in a vessel comprising glass or plastic allowing the irradiation pass through the walls of the vessel.
  • a vessel comprising glass or plastic
  • glass flasks used in the art are selected, such as Erlenmeyer flasks etc., or alternatively plastic flasks or bags may be used, which allow passing of the irradiation to the mixture/suspension.
  • the LED light or lights as defined on page 11 of this specification are preferably used.
  • Second stage Up-scaling of the primary arctic bramble suspension cell culture
  • the second stage of the method comprises up-scaling of the primary arctic bramble suspension cell culture (inoculum from the first stage), where the up-scaling is carried out in at least two steps.
  • the inoculum obtained from the first stage is sub-cultured, suitably every 10 ⁇ 5 days, and up-scaled to a volume of not more than 1000 ml.
  • a vessel of 200- 1000 ml is used, preferably of 200-500 ml containing about 30 to 80 ml of the primary arctic bramble suspension culture, using the same medium and temperature as in the first stage.
  • the culture is exposed to no irradiation, or irradiated using day- night irradiation regime using normal light or using LED light carried out as intermitting irradiation or as constant irradiation, to yield cell culture from the first step.
  • the cells are harvested using methods known in the art, and suspended in the fresh medium to provide an inoculum .
  • the inoculum from the first step is up-scaled to a volume of not more than 20 I and made up to with the fresh medium to obtain initial cell density of 10-50 g L ⁇ 1 , preferably 25-40 g L _1 .
  • a bio-reactor having the volume of 1-20 L, preferably 1- 10 L is used .
  • the suspension is grown in the bio-reactor for 7- 15 days, with optionally from 1 to 3 additions of the fresh medium .
  • cultivation conditions where the temperature is 20-28°C, preferably 22-26°C are used .
  • the dissolved oxygen (DO) is at least 10%, preferably at least 20 %.
  • Agitation speed is in the range of 20 to 300 rpm .
  • the pH is suitably uncontrolled .
  • the aeration of 0.25 - 0.5 I min- 1 may be used .
  • a suspension cell culture from the second step is obtained .
  • Preferably the same medium as in the first stage is used .
  • the culture is irradiated using day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, preferably LED light is used .
  • the second step may be carried out exposed to no irradiation .
  • the suspension cell culture from the second step may be obtained as the final product or alternatively it may be used as inoculum in a third step.
  • the cells may also be ha rvested using methods known in the art using methods known in the art and the harvested cells may be suspended in the fresh medium to provide the inoculum.
  • the second stage may also comprise a third step.
  • the inoculum from the second step is up-scaled to volume of not more than 70 I, made up to with the fresh medium to obtain initial cell density of 10-50 g L _1 , preferably 25-40 g L _1 , suitably using a bio-reactor having the volume of 10-70 L, preferably 10-50 L.
  • the suspension is grown in the bio-reactor for 7- 15 days, with optionally one addition of fresh medium.
  • cultivation conditions where the temperature is 20-28°C, preferably from 22 to 26°C, and dissolved oxygen (DO) at least 10%, preferably at least 20 % are used .
  • the agitation speed is suitably in the range of 20 - 150 rpm .
  • the pH is suitably uncontrolled .
  • the aeration is preferably 0.3 - 2 I min _1
  • the pressure is suitably in the range 0.008 to 0.2 bar, depending on cultivation vessel .
  • the same medium as in the first stage is used .
  • the culture is irradiated using day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, preferably LED light is used, particularly preferably intermitting irradiation with LED light.
  • the third step may be carried out exposed to no irradiation.
  • a suspension cell culture from the third step is obtained as the final product or alternatively it may be used as inoculum in a fourth step.
  • the cells may also be harvested using methods known in the art. The harvested cells may be suspended in the fresh medium to provide the inoculum.
  • the second stage may also comprise a fourth step.
  • the inoculum from the third step is up-scaled to volume of not more than 500 I made up to with fresh MS medium to obtain initial cell density of 10-50 g L _1 , preferably 25-40 g L _1 , suitably using a bio-reactor having the volume of 300-500 L.
  • the suspension is grown in the bio-reactor for 7-15 days, with optionally one addition of fresh medium, which may comprise 2- to 4- fold by weight of sucrose.
  • cultivation conditions where the temperature is from 20-28°C, preferably 22 to 26°C, and dissolved oxygen (DO) at least 10 %, preferably at least 20 % are used.
  • the agitation speed is suitably in the range of 50 - 100 rpm.
  • the pH is suitably uncontrolled.
  • the aeration is 10 - 20 I miir 1 .
  • the pressure is preferably 0.2 bars.
  • the same MS medium as in the first stage is used.
  • the culture is irradiated using day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation preferably LED light is used, particularly preferably intermitting irradiation with LED light.
  • a suspension cell culture comprising biomass is obtained.
  • the cells may also be harvested using methods known in the art.
  • the harvested cells may be suspended in the fresh medium.
  • the second stage may also comprise a further up-scaling steps.
  • the final product suspension cell culture comprising the biomass, obtained in the second stage, may be used as such, or alternatively it may be dried, suitably using cryo-drying or freeze-drying methods known in the art to provide a finely divided powder.
  • the cells may also be harvested using methods known in the art, and used as such or dried.
  • the pH of the MS medium used in the method may preferably be adjusted to 3.5-5, in all steps before autoclaving the medium, using 0.1 M HCI.
  • the first step is suitably carried out in a vessel comprising glass or plastic allowing the irradiation pass through the walls of the vessel.
  • a vessel comprising glass or plastic allowing the irradiation pass through the walls of the vessel.
  • glass flasks used in the art are selected.
  • the second and further up-scaling steps may be carried out in vessels, such as bioreactors allowing the cultivation to final culture volume and passing of the irradiation to the reaction mixture.
  • vessels comprising glass or plastic material may be used.
  • LED (light emitting diode) light is used in the method.
  • the LED light is used in all stages and all steps.
  • the LED light has color temperature of 2700-3000K.
  • the LED light comprises an effectual spectrum comprising at least 25 % of an integral in the wave length range of 630 nm-760 nm (red light integral), calculated from the total effectual spectrum.
  • Red light is generally classified as "warm light shade”.
  • the LED light comprises a total effectual spectrum in the wave length range of 400-800nm.
  • the LED light comprises less than 75 % of an integral in the wave length range of 400-450 nm (violet light integral) or of an integral in the wave length range of 450-490 nm (blue light integral) or of an integral in the wave length range of 490-560 nm (green light integral) or of an integral in the wave length range of 560-590 nm (orange light integral) or a combination thereof.
  • irradiation source is preferably LED light with illumination intensity over 500 Ix, preferable over 800 Ix.
  • One LED light (source) or combination of LED lights (light sources) may be used .
  • Said LED lights may be arranged in a panel surrounding or enclosing the reaction vessel, or in any other way to provide the reaction mixture the required irradiation.
  • the final product suspension cell culture comprising the biomass, obtained in the second stage, may be used as such in the manufacture of products, or alternatively it may be dried, suitably using cryo-drying or freeze-drying methods known in the art to provide a finely divided powder. Alternatively, the cells may also be harvested, and used as such or dried.
  • the biomass may be separated using technique known in the art. Suitably a filter press or vacuum filtration is used, where the biomass is filtered and washed with sterile water. The biomass filter cake is suitably dried, for example using freeze-drying.
  • the dry biomass may be ground to finely divided powder and stored in sealed packages, preferably at temperatures of about -20°C.
  • the arctic bramble cell cultures obtained with the method of the present invention exhibit high bioactivities and other beneficial and interesting properties.
  • the chemical composition of the cell cultures obtained by the method is clearly different from the one natural arctic bramble fruit.
  • high amounts of cell lines with very intense red, yellow, orange, green or purple color and unique chemical composition can be obtained in a consistent manner.
  • Natural arctic bramble berry fruit contains typically hydroxycinnamic acids and their derivatives, anthocyanins, flavonols, ellagic acid derivatives and ellagitannins, gallic acid derivatives and cathechins. Procyanidins are not found in the natural plants.
  • the arctic bramble cell cultures obtained with the method may comprise 0.1-10 wt% (dry weight) of anthocyanins and 0.1-5 wt% (dry weight) of proanthocyanidins.
  • the arctic bramble cell cultures obtained by the method of the invention comprise surprisingly significant amounts of anthocyanins, and flavonoids, such as quercetin derivatives, kaempherol derivatives, prodelphidins and procyanidins having high degree of polymerization, typically at least 13. Further, said arctic bramble cell cultures comprise typically about 200-400 mg/g of proteins, fatty acids such as a-linoleic acid and carbohydrates, such as sucrose.
  • Anthocyanins exhibit antioxidant and anti-inflammatory effect, in addition to intensive color, aroma and flavor, and thus they are beneficial for use in cosmetic, hygiene and personal care applications, in food, feeds, pet foods, nutritional products, nutraceuticals, pharmaceutical products, and for providing aroma, flavor and/or color to the products.
  • Antioxidant activity is also essential for example in delaying skin aging processes.
  • the anthocyanin content can be increased over seven-fold, particularly with the red-colored arctic bramble cell lines, compared to the manufacture under normal light conditions, and further, the content of other phenolic compounds is increased, especially the content of quercetin and procyanidin.
  • the cells obtained with the method are more intact and contain significantly less water when compared with the ones manufactured under normal light conditions. They provide an advantage as being more effective and economic in downstream processing.
  • the phenolic compounds such as flavonoids exhibit antimicrobial activity.
  • Antimicrobial activity is beneficial in cosmetic applications, where for example in cosmetic products it helps to balance skin microbiota and prevents product contaminations.
  • compositions comprising arctic bramble cell cultures obtained by the method, said arctic bramble cell cultures comprising anthocyanins, procyanidins, phenolic acids, vitamins and fatty acids beneficial for human health.
  • the invention relates also to compositions comprising arctic bramble cell cultures obtained by the method of the invention, where the composition is selected from cosmetic compositions, hygiene and personal care products, as well as in foods, feeds, pet foods nutritional compositions, nutraceutical compositions, and pharmaceutical compositions.
  • the invention relates also to the use of said arctic bramble cell cultures in compositions selected from cosmetic compositions, hygiene and personal care products, as well as in foods, feeds, pet foods nutritional compositions, nutraceutical compositions, and pharmaceutical compositions.
  • the cosmetic compositions may contain cosmetically acceptable substances in addition to said arctic bramble cell culture(s). Said compositions may be used as day creams, foundation creams, peeling creams, lipsticks, color cosmetics, skin serums, mascaras, products for hair and/or scalp care, washing products for skin or hair, and as products for skin hygiene.
  • the cosmetic composition can be, for example, an emulsion cream, such as a day cream or a foundation cream; peeling cream; a lipstick; a skin serum or a hair cosmetics product, such as a composition for hair conditioning or a composition for scalp treatment.
  • the cosmetic composition may contain the arctic bramble cell culture in powder form in an amount of 0.001 to 25 % by weight, more preferably the amount of the powder is 0.01 to 5 % by weight, and most preferably 0.01-1 % by weight.
  • the emulsion cream containing arctic bramble cell culture can be of the type oil-in-water emulsion, water-in-oil emulsion, water-oil-water emulsion or a micro-emulsion.
  • the emulsion cream composition may contain the arctic bramble cell culture in powder form, preferably 0.001 to 25 % by weight, more preferably 0.01 to 5 % by weight and most preferably 0.01 to 1 % by weight.
  • the arctic bramble cell culture can be combined also with synthetic or natural vitamins or their combinations.
  • these vitamins are retinol and A- vitamin palmitate.
  • E-vitamins and E-vitamin derivatives like tocopherol, C-vitamin and its derivatives, like ascorbyl palmitate and magnesium ascorbyl phosphate, panthenol and other B-vitamins and/or biotin may be used .
  • the composition may contain synthetic and/ or natural vitamins preferably 0.01 to 10 % by weight, more preferably 0.02 to 5 % by weight.
  • the emulsion cream compositions may contain, in addition, one or more adjuvants acceptable in the field of cosmetics, such as preservation agents, thickening agents, moisturizing agents, and other suitable additives, such as for example perfumes and/or coloring agents.
  • suitable preservation agents are for example parabens, phenoxyethanol, imidazolidinyl urea and methyldibromo glutaronitrile. These preservation agents can be used alone or combined with each other.
  • any thickening agent suitable in the field of cosmetics can be used provided, that it is compatible with the other components of the composition, for example xanthan gum and hydroxyethylcellulose, hydroxypropylmethylcellulose, Sclerotium gum, Chondrus Crispus, polyacrylates, polyacrylamides, cetearyl dimethicone crosspolymer and magnesium aluminium silicate.
  • Thickening agents can be used alone or in combination with each other. Suitable moisturizing agents are for example heptyl undecylenate, hyaluronic acid or sodium PCA.
  • skin conditioning agents for example tocopheryl acetate and ethylhexylglycerin may be used.
  • one or more compounds acting as an emulsifier i.e. a compound dispersing and stabilizing the oil in water may be needed in the emulsion cream composition.
  • Useful emulsifiers are all non-ionic emulsifiers accepted by the cosmetic legislation, such as, for example, glyceryl stearate, PEG-5 glyceryl stearate, PEG-1 00 stearate, PEG-30 dipolyhydroxystearate, lecithin, hydrogenated lecithin and PEG- 8 bees wax, steareth-21, steareth-2, sorbitan olivate as well as a mixture of a fatty glucoside, such as for example cetearyl, cocoyl, or myristyl glucoside and a fatty alcohol, such as for example cetearyl, cetyl, stearyl, octyldodecanol, caprylic/capric triglyceride or myr
  • the peeling cream compositions contain arctic bramble cell culture preferably 0.001 to 25 % by weight, more preferably 0.01 to 5 % by weight and most preferably 0.01 to 1 % by weight.
  • the peeling cream compositions may contain in addition to arctic bramble cell culture also other substances, which are acceptable in the field of cosmetics and which are traditional components of peeling cream compositions.
  • Peeling cream compositions can also contain emulsifiers like PEG-8, behenyl alcohol, arachidyl glucoside and arachidyl alcohol, thickening agents like ethylcellulose and various vitamins and derivatives of those, like tocopherol, ascorbyl palmitate and ascorbic acid.
  • the peeling cream compositions can in addition contain one or more adjuvants and/or additives acceptable in the field of cosmetics, such as preservation agent. Suitable preservation agents are for example parabens and phenoxyethanol. These preservation agents can be used alone or in combination with each other.
  • the lipstick compositions contain arctic bramble cell culture preferably 0.001 to 25 % by weight, more preferably 0.01 to 5 % by weight and most preferably 0.01 to 2 % by weight.
  • the lipstick compositions may contain in addition to arctic bramble cell culture also other substances, like different waxes, oils, coloring and pearlescent agents, which are acceptable in the field of cosmetics and which are traditional components of lipstick compositions.
  • Usable waxes are the natural waxes, such as bees wax, candelilla, carnauba, cereal based waxes, jojoba wax and their derivatives, in addition paraffin waxes and synthetic polyethylenes.
  • Lipstick compositions can also contain emulsifiers like PEG-8, behenyl alcohol, arachidyl glucoside and arachidyl alcohol, thickening agents like ethylcellulose and various vitamins and derivatives of those, like tocopherol, ascorbyl palmitate and ascorbic acid.
  • the lipstick compositions can in addition contain one or more adjuvants and/or additives acceptable in the field of cosmetics, such as preservation agent.
  • Suitable preservation agents are for example parabens and phenoxyethanol. These preservation agents can be used alone or in combination with each other.
  • the compositions intended for hair or scalp care may contain arctic bramble cell culture, preferably 0.001 to 10 % by weight, more preferably 0.01 to 5 % by weight and most preferably 0.01 to 2 % by weight. Further, the compositions intended for hair or scalp care may also contain different caring agents. These caring agents are typically in the amount of 0.1 to 40 % by weight. Preferably the caring agent content of a product is 0.1 to 20 % by weight.
  • compositions intended for hair or scalp care may contain in addition to arctic bramble cell culture, also other substances acceptable in the field of cosmetics, like cationically active substances, such as cetrimonium chloride, in addition an emulsion forming substance, such as for example cetyl alcohol, cetearyl alcohol, ceteareth-20.
  • the compositions intended for hair or scalp care can contain one or more adjuvants acceptable in the field of cosmetics, such as a cellulose derivative, ethanol and/or water.
  • oils, waxes and fatty alcohols can be present in the compositions, according to the invention, intended for hair or scalp care.
  • the serum compositions may contain arctic bramble cell culture preferably 0.001 to 25 % by weight, more preferably 0.01 to 5 % by weight and most preferably 0.01 to 2 % by weight.
  • the serum compositions may contain also other substances acceptable in the field of cosmetics such as emulsifying agents, chelating agents, solvents, preservatives, stabilizers together with substances affecting the skin permeability of the composition. These substances may be e.g.
  • methylpropanediol glycerin, phenoxyethanol, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, xanthan gum, propanediol, ammonium acryloyldimethyltaurate/VP copolymer, polyisobutene, disodium EDTA, lecithin, glucose, hydrogenated phosphatidylcholine, inulin lauryl carbamate, PEG-7, trimethylolpropane coconut ether, chondrus crispus, ethyl pyrrolidone, and cellulose gum.
  • the serum compositions may contain different moisturizing and skin conditioning agents such as heptyl undecylenate, ethylhexylglycerin, caprylyl glycol, ethylhexyl cocoate, peat extract and glycolipids.
  • moisturizing and skin conditioning agents such as heptyl undecylenate, ethylhexylglycerin, caprylyl glycol, ethylhexyl cocoate, peat extract and glycolipids.
  • the arctic bramble cell culture is preferably used in the form of freeze-dried powder, and the amounts given above are calculated for said powder.
  • methanol or ethanol extracts it is within the expertise of a person skilled in the art to adapt the amounts correspondingly.
  • the phenolic profile of the arctic bramble cell cultures of the present invention is unique and different compared to the arctic bramble berry fruit, as said cell cultures may contain procyanidins, gallic acid derivatives, kampherol derivatives, quercetin derivatives, vitamin
  • E (a-tocopherol), unique carbohydrate composition and unique fatty acid composition.
  • Some of the culture lines produce high amounts of natural colorants, i.e. anthocyanins.
  • the cell cultures also contain natural flavors and lipids with beneficial fatty acid composition, which are desired ingredients in cosmetic and hygiene preparations.
  • the cell cultures can be generated around the year at different scales in consistent quality, which can be constantly monitored. It was surprisingly found that several advantageous effects may be achieved with the present invention.
  • the cultures were sub-cultured after 11 +/- 3 days by diluting cultures 1 : 3 with the fresh medium, and the clumps of the callus were removed. After 4 - 8 sub-culturing the cell lines in suspension were used as inoculum in bioreactor up-scaling.
  • the inoculum was red-coloured arctic bramble suspension cell culture (KAS 341/15), obtained from arctic bramble plant material with a method consisting of formation of calli and generation of suspension cell culture by favouring dark red coloured calli, as described in example 1.
  • Said arctic bramble suspension cell culture was used as inoculum in glass bioreactors under illumination of LED light panel with light intensity of 860 Ix, colour temperature 2700-3000K, spectral range of 450-780 nm, with at least 25 % of the emission in the range of 630-760 nm (fermenter A).
  • a reference study was conducted with normal light of 120 Ix in pilot hall (fermenter B).
  • Inoculum in both fermenters A and B comprising of arctic bramble cells (KAS 341/15) was made up to with the fresh MS medium described in example 1, to obtain initial cell density of 30 g L "1 , for bio-reactors A and B having the volume of 2 L.
  • the suspensions were grown in the both bio-reactors for 9 days.
  • the cultivation conditions were the following : temperature 25°C, dissolved oxygen (DO) over 20 %, agitation speed 100-300 rpm, pH was followed but not controlled, aeration with pressurized air 1.5 l/min, continuous expose to light (LED or normal). Sampling was carried out after 3 and 6 days, where the viability of the cells was tested with FDA (Fluorescein Diacetate) staining.
  • Figure 1 shows anthocyanin contents (peak at about 3.1) of arctic bramble cell cultures obtained with LED irradiation (A) and without it (B).

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
EP17873936.3A 2016-11-24 2017-11-22 Zellkulturen der allackerbeere (arcticus rubus), verfahren zur herstellung von allackerbeerenzellkulturen, zusammensetzungen mit allackerbeerenzellkulturen und verwendung von allackerbeerenzellkulturen Pending EP3544411A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20165897A FI128318B (en) 2016-11-24 2016-11-24 Honeycomb (RUBUS ARCTICUS) Cell Cultures, Method for Producing Honeycomb Cell Cultures, Compositions comprising Honeycomb Cell Cultures, and Use of Honeycomb Cell Cultures
PCT/FI2017/050808 WO2018096212A1 (en) 2016-11-24 2017-11-22 Arctic bramble (rubus arcticus) cell cultures, method for producing arctic bramble cell cultures, compositions comprising arctic bramble cell cultures and use of arctic bramble cell cultures

Publications (2)

Publication Number Publication Date
EP3544411A1 true EP3544411A1 (de) 2019-10-02
EP3544411A4 EP3544411A4 (de) 2020-04-29

Family

ID=62195788

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17873936.3A Pending EP3544411A4 (de) 2016-11-24 2017-11-22 Zellkulturen der allackerbeere (arcticus rubus), verfahren zur herstellung von allackerbeerenzellkulturen, zusammensetzungen mit allackerbeerenzellkulturen und verwendung von allackerbeerenzellkulturen

Country Status (4)

Country Link
EP (1) EP3544411A4 (de)
KR (1) KR102646959B1 (de)
FI (1) FI128318B (de)
WO (1) WO2018096212A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20175668A (fi) * 2017-07-07 2019-01-08 Teknologian Tutkimuskeskus Vtt Oy Menetelmä betulaceae-perheen soluviljelmien tuottamiseksi, mainittuja soluviljelmiä käsittävät koostumukset ja mainittujen soluviljelmien käyttö
CN109496843A (zh) * 2018-11-21 2019-03-22 内蒙古医科大学 一种库页悬钩子不定芽组织培养快速繁殖方法
CN110810241A (zh) * 2019-11-22 2020-02-21 江苏东郁植物科技有限公司 一种树莓的组织培养种苗繁殖方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3737417B2 (ja) * 2001-01-19 2006-01-18 パク、キ−ヨエウ 組織培養による人参・樟脳参・山参の不定根の大量増殖方法およびサポニン含量の改善方法
JP5712672B2 (ja) * 2010-02-09 2015-05-07 国立大学法人 宮崎大学 ブルーベリーの栽培方法
GB201108519D0 (en) * 2011-05-20 2011-07-06 Naturally Scient Technologies Ltd Photosynthetic process

Also Published As

Publication number Publication date
FI20165897A (fi) 2018-05-25
KR20190089012A (ko) 2019-07-29
WO2018096212A1 (en) 2018-05-31
EP3544411A4 (de) 2020-04-29
KR102646959B1 (ko) 2024-03-14
FI128318B (en) 2020-03-13
FI20165897L (fi) 2018-05-25

Similar Documents

Publication Publication Date Title
EP2260829B1 (de) Verwendung eines Extraktes aus Schneealgen in kosmetischen oder dermatologischen Formulierungen
KR20090129963A (ko) 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 노화 방지 또는 항산화용 조성물
KR102646959B1 (ko) 아르크티크 브램블 (루부스 아르티쿠스) 세포 배양물, 아르크티크 브램블 세포 배양물을 생성하는 방법, 아르크티크 브램블 세포 배양물을 포함하는 조성물, 및 아르크티크 브램블 세포 배양물의 용도
Imchen et al. Marine algae colorants: Antioxidant, anti-diabetic properties and applications in food industry
KR101372789B1 (ko) 장미 태좌 조직 배양물 또는 그 추출물을 함유하는 피부 외용제 조성물 및 기능성 식품
FI124984B (fi) Puolukkauutefraktioita sisältävät kosmeettiset koostumukset
KR102354412B1 (ko) 혼합 꽃 추출물의 유산균 발효물을 유효성분으로 함유하는 화장료 조성물
Patel Reviewing the prospects of Opuntia pears as low cost functional foods
Abyari et al. Enhanced accumulation of scopoletin in cell suspension culture of Spilanthes acmella Murr. using precursor feeding
EP2817070B1 (de) Kosmetische zusammensetzungen mit einem moltebeeren-zellkulturpräparat
KR20200004134A (ko) 포도 캘러스 배양액을 유효 성분으로 함유하는 피부 개선용 조성물
US9763873B2 (en) Preparation for protecting against extrinsic and intrinsic skin aging
JP2021045127A (ja) カロテノイドの大量生産方法
WO2019008225A1 (en) METHOD FOR PRODUCING BETULACEAE FAMILY CELL CULTURES, COMPOSITIONS COMPRISING THE CELL CULTURES AND USE OF THE CELL CULTURES
KR20120057370A (ko) 은행나무과의 형성층 유래 식물줄기세포를 유효성분으로 함유하는 항노화용 조성물
ES2686502T3 (es) Utilización de células vegetales de buganvilia para la encapsulación de ingredientes activos
KR101694660B1 (ko) 항염증 효과가 있는 암(暗) 조건에서 최아된 들깨새싹 추출물
EP2441433B1 (de) Olleya marilimosa und dessen Verwendung in einem Verfahren zur Herstellung einer Zusammensetzung enthaltend Zeaxanthin
KR101567325B1 (ko) 국화 추출물을 포함하는 식품 조성물
CN111991276A (zh) 一种含沙漠藻提取物的保湿面霜及制备方法
KR101291460B1 (ko) 섬오갈피나무의 캘러스 추출물을 함유하는 피부 외용제 조성물
KR20180137729A (ko) 스피룰리나 생산증진을 위한 미네랄 함유 배지조성물 및 이를 이용한 스피룰리나 대량생산 방법
Smith et al. Stimulation of bioactive flavonoid production in suspension and bioreactor-based cell cultures
BURAN et al. Determination of Total Phenolic and Flavonoid Content and Total Antioxidant Capacity of Ficus elastica Callus Cultures
JPH0987620A (ja) 子葉処理体及びその製造方法

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190603

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20200330

RIC1 Information provided on ipc code assigned before grant

Ipc: A23L 19/00 20160101ALI20200324BHEP

Ipc: A01H 4/00 20060101AFI20200324BHEP

Ipc: A61K 8/97 20170101ALI20200324BHEP

Ipc: C12N 5/04 20060101ALI20200324BHEP

Ipc: A61K 36/73 20060101ALI20200324BHEP

Ipc: C12N 5/00 20060101ALI20200324BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240202